Data  underlying the publication: Validation of a novel medical device (Chloe SED®) for the administration of analgesia during manual vacuum aspiration: a randomized controlled non-inferiority pilot study

doi:10.4121/7e08e77b-f4a9-4054-81a5-e83b7946cb21.v1
The doi above is for this specific version of this dataset, which is currently the latest. Newer versions may be published in the future. For a link that will always point to the latest version, please use
doi: 10.4121/7e08e77b-f4a9-4054-81a5-e83b7946cb21
Datacite citation style:
Samenjo, Karlheinz; Ramanathan, Aparna; Gwer, Stephen; Bailey, Robert; Imbamba, Javan et. al. (2024): Data  underlying the publication: Validation of a novel medical device (Chloe SED®) for the administration of analgesia during manual vacuum aspiration: a randomized controlled non-inferiority pilot study. Version 1. 4TU.ResearchData. dataset. https://doi.org/10.4121/7e08e77b-f4a9-4054-81a5-e83b7946cb21.v1
Other citation styles (APA, Harvard, MLA, Vancouver, Chicago, IEEE) available at Datacite
Dataset

This dataset assesses the efficacy of Chloe SED®, a novel device for administering analgesia during manual vacuum aspiration (MVA), through a multisite, randomized controlled non-inferiority trial aimed at comparing its effectiveness to the standard spinal needle in providing humane care for abortion or miscarriage procedures in low-resource Kenyan healthcare settings. Data captures patient pain tolerance and experiences with Chloe SED® versus the spinal needle, gestational age, prior MVA experiences, reasons for MVA, as well as healthcare providers’ perceptions of pain control and their experience with MVA procedures. The dataset enables a comprehensive comparison of pain control outcomes between Chloe SED® and the standard method, providing insight into the device's potential for improving care quality.

history
  • 2024-10-28 first online, published, posted
publisher
4TU.ResearchData
format
Excel spreadsheet
organizations
TU Delft, Faculty of Industrial Design Engineering, Department of Sustainable Design Engineering.
National Center for Advanced Pelvic Surgery, Department of Obstetrics and Gynecology, Medstar Washington Hospital Center, Georgetown University, Washington, DC, United States.
Nyanza Reproductive Health Society, Kisumu, Kenya.
Department of Epidemiology, University of Illinois at Chicago School of Public Health, Chicago, IL, United States.
Department of Obstetrics and Gynaecology, Maseno University, Kisumu, Kenya

DATA - restricted access

Reason

Study raw data can be accessed upon reasonable request. Data is treated as clinical and requires adherence to ethical procedures. Contact j.c.diehl@tudelft.nl

End User Licence Agreement

Despite anonymisation efforts, the small sample size presents a risk of respondent identification and thus requires careful handling.


End User Licence Agreement

  1. Licence Grant: Licensor grants a limited, non-exclusive, non-transferable licence to access the Data solely for research purposes. No ownership rights in the Data are transferred to you, and the Licensor reserves all such rights.
  2. Data Integrity: The Data is provided "AS IS," without warranties on accuracy or reliability, and Licensor holds no liability for errors or damages.
  3. Intellectual Property: All rights in the Data, including copyrights and proprietary information, remain with Licensor.
  4. Termination: Licensor may terminate access at any time for violations, requiring immediate cessation and data destruction.
  5. Limitation of Liability: Licensor is not liable for any damages arising from Data use, including loss of revenue or data.
  6. Indemnification: You agree to indemnify Licensor and its affiliates from claims or damages related to your data use or agreement violations.
  7. Restrictions
  • No Redistribution: Do not share, sell, or sublicense the Data to third parties.
  • Non-Commercial Use Only: Commercial use is prohibited.
  • No Modifications: Do not modify, translate, or create derivative works without permission.
  • Prohibited Uses: Do not use the Data in illegal, unethical, or infringing ways.



▶  Request access to data.

Your request will be sent to the owner of the dataset.

Send request for access to data